novo nordisk glp-1 receptor agonists weight management diabetes treatments Saxenda (liraglutide) for the Treatment of Obesity, US Novo Nordisk, Eli Lilly Slip
Description
Zhao P, Liang Y-L, Belousoff MJ, et al
:max_bytes(150000):strip_icc()/GettyImages-16924367652-9ad3c91c6df34bc29f1c28f0b773d643.jpg)
First, the follow-up data were available for different time frames
The company said the goal is to treat weight management as a long-term condition rather than a one-time prescription
Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk
High-dimensional characterization of post-acute sequelae of COVID-19
